Anaphylatoxins in fresh-frozen plasma

Transfusion

Volumn 37, Issue 8, 1997, Pages 798-803

  Sonntag, J ^a   Stiller, B ^b   Walka, M M ^c   Maier, R F ^c  

^a HUMBOLDT UNIVERSITY   (Germany)

^b DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; ANAPHYLATOXIN; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C5A; FRESH FROZEN PLASMA;

APHERESIS; ARTICLE; BLOOD CLOTTING DISORDER; COMPLEMENT ACTIVATION; HEMOLYSIS; HUMAN; REFERENCE VALUE; TRANSFUSION;

EID: 0030840632     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1997.37897424401.x     Document Type: Article

References (34)

1. Goldstein IM. Complement: biologically active products. In: Gallin JI, Goldstein IM, Snyderman R, eds. Inflammation: basic principles and clinical correlates. New York: Raven Press, 1992:63-80.
2. Vogt W. Anaphylatoxins: possible roles in disease. Complement 1986;3:177-88.
3. Hack CE, Nuijens JH, Felt-Bersma RJ, et al. Elevated plasma levels of the anaphylatoxins C3a and C4a are associated with a fatal outcome in sepsis. Am J Med 1989;86:20-6.
4. Hammerschmidt DE, Weaver LJ, Hudson LD, et al. Association of complement activation and elevated plasma -C5a with adult respiratory distress syndrome. Pathophysiological relevance and possible prognostic value. Lancet 1980;1:947-9.
5. Gelfand JA, Donelan M, Burke JF. Preferential activation and depletion of the alternative complement pathway by burn injury. Ann Surg 1983;198:58-62.
6. Chenoweth DE, Cooper SW, Hugli TE, et al. Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins. N Engl J Med 1981;304:497-503.
7. Salat C, Holler E, Schleuning M, et al. Levels of the terminal complement complex, C3a-desArg and C1-inhibitor in adult patients with capillary leak syndrome following bone marrow transplantation. Ann Hematol 1995;71:271-4.
8. Snyder AJ, Gottschall JL, Menitove JE. Why is fresh-frozen plasma transfused? Transfusion 1986;26:107-12.
9. Blumberg N, Laczin J, McMican A, et al. A critical survey of fresh-frozen plasma use. Transfusion 1986;26:511-3.
10. Consensus conference. Fresh-frozen plasma. Indications and risks. JAMA 1985;253:551-3.
11. Contreras M, Ala FA, Greaves M, et al. Guidelines for the use of fresh frozen plasma. British Committee for Standards in Haematology, Working Party of the Blood Transfusion Task Force. Transfus Med 1992;2:57-63.
12. Hashim SW, Kay HR, Hammond GL, et al. Noncardiogenic pulmonary edema after cardiopulmonary bypass. An anaphylactic reaction to fresh frozen plasma. Am J Surg 1984;147:560-4.
13. Rosenkvist J, Berkowicz A, Holsoe E, et al. Plasma exchange in myasthenia gravis complicated with complement activation and urticarial reactions using fresh-frozen plasma as replacement solution. Vox Sang 1984;46:13-8.
14. Busund R, Balteskard L, Ronning G, et al. Fatal myocardial depression and circulatory collapse associated with complement activation induced by plasma infusion in severe porcine sepsis. Acta Anaesthesiol Scand 1995;39:100-8.
15. Bacher T, Pedersen JO, Lylloff K, et al. [Production of fresh frozen plasma by machine plasmapheresis.] (Engl abstract) Ugeskr Laeger 1985;147:700-3.
16. Senaldi G, Peakman M, Alhaq A, et al. Activation of the alternative complement pathway: clinical application of a new technique to measure fragment Ba. J Clin Pathol 1987;40:1235-9.
17. Kolde HJ, Deubel R. Development of a rapid kinetic assay for the function of the classical pathway of the complement system and for C2 and C4. J Clin Lab Immunol 1986;21:201-7.
18. Mancini G, Carbonara AO, Heremans JF. Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry 1965;2:235-54.
19. Klos A, Ihrig V, Messner M, et al. Detection of native human complement components C3 and C5 and their primary activation peptides C3a and C5a (anaphylatoxic peptides) by ELISAs with monoclonal antibodies. J Immunol Methods 1988;111:241-52.
20. Moore FD Jr, Davis C, Rodrick M, et al. Neutrophil activation in thermal injury as assessed by increased expression of complement receptors. N Engl J Med 1986;314:948-53.
21. Zilow G, Zilow EP, Burger R, Linderkamp O. Complement activation in newborn infants with early onset infection. Pediatr Res 1993;34:199-203.
22. Oppermann M, Schulze M, Götze O. A sensitive enzyme immunoassay for the quantitation of human C5a/C5a(desArg) anaphylatoxin using a monoclonal antibody with specificity for a neoepitope. Complement Inflamm 1991;8:13-24.
23. Wagner MH, Sonntag J, Waiss E, Obladen M. Complement activation after birth asphyxia (abstract). Pediatr Res 1996;40:556.
24. Watson JW, Drazen JM, Stimler-Gerard NP. Synergism between inflammatory mediators in vivo. Induction of airway hyperresponsiveness to C3a in the guinea pig. Am Rev Respir Dis 1988;137:636-40.
25. Hoffmann T, Böttger EC, Baum HP, et al. In vivo effects of C3a on neutrophils and its contribution to inflammatory lung processes in a guinea-pig model. Clin Exp Immunol 1988;71:486-92.
26. Randomized trial of prophylactic early fresh-frozen plasma or gelatin or glucose in preterm babies: outcome at 2 years. Northern Neonatal Nursing Initiative Trial Group. Lancet 1996;348:229-32; comment, 208-9.
27. Johnson RJ, Burhop KE, Van Epps DE. Infusion of ovine C5a into sheep mimics the inflammatory response of hemodialysis. J Lab Clin Med 1996;127:456-69.
28. Schött U, Berseus O, Järemo P. Blood substitution and complement activation. Acta Anaesthesiol Scand 1987;31:559-66.
29. Holme S, Snyder E, Heaton A, et al. In vitro and in vivo evaluation of cotton wool filtration of platelet concentrates obtained by automated and manual apheresis. Transfusion 1992;32:328-33.
30. Weisdorf DJ, Hammerschmidt DE, Jacob HS, Craddock PR. Rapid in vivo clearance of C5ades arg: a possible protective mechanism against complement-mediated tissue injury. J Lab Clin Med 1981;98:823-30.
31. Boogaerts MA, Roelant C, Goossens W, Verwilghen RL. Complement activation and adult respiratory distress syndrome during intermittent flow apheresis procedures. Transfusion 1986;26:82-7.
32. Schleuning M, Schmid-Haslbeck M, Utz H, et al. Complement activation during storage of blood under normal blood bank conditions. Effects of proteinase inhibitors and leukocyte depletion. Blood 1992;79:3071-5.
33. Söhngen D, Kretschmer V, Franke K, et al. Thawing of fresh-frozen plasma with a new microwave oven. Transfusion 1988;28:576-80.
34. Rock G, Tackaberry ES, Dunn JG, Kashyap S. Rapid controlled thawing of fresh-frozen plasma in a modified microwave oven. Transfusion 1984;24:60-5.